Cardiovascular autonomic regulation in patients with 3243A>G mitochondrial DNA mutation

Annals of Medicine

Volumn 36, Issue 3, 2004, Pages 225-231

  Majamaa Voltti, Kirsi ^a   Majamaa, Kari ^a   Peuhkurinen, Keijo ^b   Mäkikallio, Timo H ^a   Huikuri, Heikki V ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Autonomic dysfunction; Cardiac hypertrophy; Heart rate variability; Mitochondrial DNA mutation; Phenotype

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DNA POLYMORPHISM; EVALUATION; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HEMODYNAMICS; HETEROPLASMY; HUMAN; MALE; MITOCHONDRIAL DNA DISORDER; MORBIDITY; MORTALITY; NUCLEOTIDE SEQUENCE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SPECTROSCOPY;

ADULT; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MUTATION;

EID: 2542492459     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890410028456     Document Type: Article

References (44)

1. Pavlakis SG, Philips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neur 1984;16:481-8.
2. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 1997;120:1713-21.
3. Kärppä M, Syrjälä P, Tolonen U, Majamaa K. Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA. J Neurol 2002;250:216-21.
4. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, et al. Cardiac involvement in mitochondrial diseases: A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995;91:955-61.
5. Majamaa-Voltti K, Peuhkurinen K, Kortelainen M-L, Hassinen I, Majamaa K. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord 2002;2:12.
6. Antozzi C, Zeviani M. Cardiomyopathies in disorders of oxidative metabolism. Cardiovasc Res 1997;35:184-99.
7. Kleiger RE, Miller JP, Bigger JT, Moss AJ, for the Multicenter Postinfarction Research Group. Decreased heart rate variability and its association with increased mortality after myocardial infarction. Am J Cardiol 1987;59:256-62.
8. Mäkikallio T, Huikuri H, Hintze U, Videbæk J, Mitrani R, Castellanos A, et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001;87:178-82.
9. Farrel TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and signal-averaged electrocardiogram. J Am Coll Cardiol 1991;18:687-97.
10. Mäkikallio T, Huikuri HV, Mäkikallio A, Sourander LB, Mitrani RD, Castellanos A, et al. Prediction of sudden cardiac death by fractal analysis of heart rate variability in elderly subjects. J Am Coll Cardiol 2001;37:1395-402.
11. Tsuji H, Venditti FJ, Jr, Manders ES, Evans JC, Larson MG, Feldman CL, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994;90:878-83.
12. Huikuri HV, Mäkikallio T, Airaksinen KE, Mitrani R, Castellanos A, Myerburg RJ. Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol 1999;34:1878-83.
13. Huikuri HV, Mäkikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000;101:47-53.
14. Huikuri HV, Seppänen T, Koistinen MJ, Airaksinen J, Ikäheimo MJ, Castellanos A, et al. Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarction. Circulation 1996;93:1836-44.
15. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Kärppä M, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998;63:447-54.
16. Uimonen S, Moilanen JS, Sorri M, Hassinen IE, Majamaa K. Hearing impairment in patients with 3243A>G mtDNA mutation: phenotype and rate of progression. Hum Genet 2001;108:284-9.
17. Rankin J. Cerebral vascular accidents in patients over the age of 60. 2. Prognosis. Scot Med J 1957;2:200-15.
18. Guy E. Clinical global impressions. Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology. National Institute of Mental HealthRockville1976: 218-22.
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
20. Huikuri HV, Ylitalo A, Pikkujämsä S, Ikäheimo MJ, Airaksinen KE, Rantala AO, et al. Heart rate variability in systemic hypertension. Am J Cardiol 1996;77:1073-7.
21. Pikkujämsä SM, Mäkikallio TH, Sourander LB, Räihä IJ, Puukka P, Skyttä J, et al. Cardiac interbeat interval dynamics from childhood to senescence: Comparison of conventional and new measures based on fractals and chaos theory. Circulation 1999;100:393-9.
22. Huikuri HV, Mäkikallio TH, Airaksinen KEJ, Seppänen T, Puukka J, Räihä IJ, et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation 1998;97:2031-6.
23. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043-65.
24. Bigger JT, Steinman RC, Rolnitzky L, Fleiss JL, Albrectht P, Cohen RJ. Power law behaviour of RR-interval variability in healthy middle aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation 1996;21:2142-51.
25. Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 1995;5:82-7.
26. Ho KK, Moody GB, Peng CK, Mietus JE, Larson MG, Levy D, et al. Predicting survival in heart failure cases and controls using fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation 1997;96:842-8.
27. Airaksinen KEJ, Hartikainen JEK, Huikuri HV, Mussalo HM, Tahvanainen KUO. Valsalva manoeuvre in the assessment of baroreflex sensitivity in patients with coronary artery disease. Eur Heart J 1993;14:1519-23.
28. Kobayashi Y, Momoi MY, Tominaga K, Momoi T, Nihei K, Yanagisawa M, et al. A point mutation in the mitochondrial tRNALeu(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes). Biochem Biophys Res Commun 1990;173:816-22.
29. Mäkimattila S, Schlenzka A, Mäntysaari M, Bergholm R, Summanen P, Saar P, et al. Predictors of abnormal cardiovascular autonomic function measured by frequency domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care 2000;23:1686-93.
30. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999;84:687-91.
31. Takase B, Kurita A, Noritake M, Uehata A, Maruyama T, Nagayoshi H, et al. Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure. J Electrocardiol 1992;25:79-88.
32. Chakko S, Mulingtapang RF, Huikuri HV, Kessler KM, Materson BJ, Myerburg RJ. Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease. Am Heart J 1993;126:1364-72.
33. Petretta M, Marciano F, Bianchi V, Migaux ML, Valva G, De Luca N, et al. Power spectral analysis of heart period variability in hypertensive patients with left ventricular hypertrophy. Am J Hypertens 1995;8:1206-13.
34. Muiesan ML, Rizzoni D, Zulli R, Castellano M, Bettoni G, Porteri E, et al. Power spectral analysis of the heart rate in hypertensive patients with and without left ventricular hypertrophy: the effect of a left ventricular mass reduction. J Hypertens 1998;16:1641-50.
35. Bigger JT, Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
36. Maassen JA, Kadowaki T. Maternally inherited diabetes and deafness: a new subtype. Diabetologia 1996;39:375-82.
37. Perkiomäki JS, Ikäheimo MJ, Pikkujämsä SM, Rantala A, Lilja M, Kesäniemi YA, et al. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Hypertension 1996;28:16-21.
38. Haapaniemi TH, Pursiainen V, Korpelainen JT, Huikuri HV, Sotaniemi KA, Myllylä VV. Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:305-10.
39. Ansakorpi H, Korpelainen JT, Huikuri HV, Tolonen U, Myllylä VV, Isojärvi JI. Heart rate dynamics in refractory and well controlled temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2002;72:26-30.
40. Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanism underlying very-low-frequency RR-interval oscillations in humans. Circulation 1998;98:547-55.
41. Tulppo MP, Mäkikallio TH, Seppänen T, Shoemaker K, Tutungi E, Hughson HL, et al. Effects of pharmacological adrenergic and vagal modulation on fractal heart rate dynamics. Clin Physiol 2001;21:515-23.
42. Kitney RI. An analysis of the nonlinear behaviour of the human thermal vasomotor control system. J Theor Biol 1975; 52:231-48.
43. Bernardi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res 1996;32:234-7.
44. Vissing J, Galbo H, Haller RG. Exercise fuel mobilisation in mitochondrial myopathy: a metabolic dilemma. Ann Neurol 1996;40:655-62.